잡앤조이 | 매거진한경

[순천대학교 2025년 초기창업패키지 딥테크 분야 선정기업] 과학적 근거에 기반한 기능성 의류를 개발하는 헬스테크 스타트업 ‘비센스’

비센스(B-SENS)는 생체역학과 한의학적 경혈 이론, 그리고 AI 기반 맞춤 기술을 융합하여 과학적 근거에 기반한 기능성 의류를 개발하는 헬스테크 기업이다. 스포츠 활동 중 자신의 움직임 수행력을 향상할 수 있는 스마트 기능성 양말 및 웨어러블 제품을 연구·개발하고 있다. 비센스의 목표는 단순한 제품을 넘어, ‘인체 감각을 활성화하는 기술’을 통해 건강하고 활력 있는 삶의 변화를 제공하는 것이다. 구도훈 대표(42)가 2024년 8월에 설립했다.“비센스는 생체역학과 한의학, 그리고 인공지능 기술을 융합하여 과학적 근거에 기반한 기능성 의류를 개발하는 헬스테크 스타트업입니다. 우리의 목표는 사람들이 일상에서 손쉽게 건강을 관리하고, 스포츠 활동 중에는 자신의 움직임 수행력을 높일 수 있도록 돕는 것입니다. 단순히 양말을 신는 행위가 건강관리의 시작이 될 수 있도록, 기술과 과학이 결합한 새로운 형태의 웰니스 경험을 제공하고 있습니다.”대표 아이템은 크게 2가지로 나뉜다. 스포츠 생활인을 위한 ‘운동 수행력 보조 양말’과 일상생활 건강 증진을 위한 ‘한의 AI 기반 족부 경혈 자극 기능성 양말’이다.“흔히 발을 ‘제2의 심장’이라고 부릅니다. 발에는 인체 각 기관과 연결된 수많은 경혈점이 분포되어 있고, 이 경혈점을 어떻게 자극하느냐에 따라 혈류가 개선되거나 근육 반응, 균형 능력 등이 달라집니다. 비센스는 한방 AI 알고리즘을 통해 개인의 발 구조, 체중 분포, 건강 상태를 분석하고, 그 데이터를 기반으로 발바닥의 경혈점을 자극할 수 있는 최적의 구조체를 설계합니다. 이 구조체는 TPU나 TPE 같은 탄성 소재를 활용해 3D 프린팅

2026.01.19 01:33:07
[순천대학교 2025년 초기창업패키지 딥테크 분야 선정기업] 현장·구급차·병원 데이터를 통합해 제공하는 응급의료 AI 기업 ‘달구’

달구(DALLGOO)는 응급의료 AI 기업으로, 환자 발생 현장, 구급차, 수용병원을 실시간 데이터로 연결해 더 안전하고 빠른 이송 결정을 돕는다. 박시은 대표(43)가 2024년 9월에 설립했다.“달구는 현장·구급차·병원 데이터를 통합해, 의료적 이동이 필요한 환자에게 Right Time, Right Place, Right Care를 구현하는 최적의 이송수단(ALS·BLS·NEMT)을 탐지·분류·배차합니다.”Right Time·Right Place·Right Care 환자에게 올바른 시간에, 올바른 장소에서, 올바른 수준의 처치·이송수단을 제공한다는 달구의 핵심 슬로건이자 임상 철학이다.대표 아이템은 ‘TechBulance Trinity’다. TechBulance Trinity는 배차 플랫폼(MedTrans AI), 실시간 동기화 모듈 (CMS-Edge), 의사결정 엔진(IMT²-Engine)으로 구성된다.TechBulance Trinity는 달구의 핵심 통합 솔루션 브랜드명으로, 배차 플랫폼 MedTrans AI, 실시간 동기화 모듈 CMS-Edge, 의사결정 엔진 IMT²-Engine 세 가지 모듈을 하나로 묶어 부르는 이름이다.배차 플랫폼(MedTrans AI)은 환자 상태, 이동 목적, 병상 상황, 거리·교통 등을 종합해 의학적으로 타당한 매칭을 우선으로 한다. 실시간 동기화(CMS-Edge)는 구급차 모니터(맥박·혈압 등), 바디캠·차량 CCTV 정보를 자동 기록·표준화하여 병원과 동기화하는 기능이다. (HL7 FHIR 지향). 장비·처치 로그도 남는다. 의사결정 엔진(IMT²-Engine)은 실시간 멀티모달 데이터를 근거로 앰뷸런스 필요성과 운송 모드(ALS·BLS·NEMT)를 보수적으로 판단해 과소 분류 위험을 낮추고 불필요 이송을 줄인다. 현재 광주권에서 구급차 5대, 일 25~30건 처리, 누적 약 3,500건의 멀티모달 데이터(파일럿·실증)

2026.01.19 01:31:02
Jaesun Lee, CEO of Incheon Center for Creative Economy & Innovation, “Youth Global Launchpad Program Lays the Foundation for Growing as a Global Young CEO”

The Incheon Center for Creative Economy & Innovation, established in 2015, is a prominent professional support organization for startups in Incheon. Registered as the first accelerator in the Incheon region in 2018, the center has led the startup and investment ecosystem in the city through childcare, commercialization support, direct investment, and investment projects.The Incheon Center for Creative Economy & Innovation is a specialized organization for startups and supports the innovative growth of startup companies through various startup support programs, such as the ICCE Entrepreneurship School and the Youth Entrepreneurship Challenge.Moreover, the Center promotes a wide range of open innovation projects to quickly enter the market for startups. Aside from Hanjin Group and KT Group, which are major corporate partners of the Incheon Center for Creative Economy & Innovation, the Center supports the rapid growth of startups by expanding its open innovation business with various large and medium-sized companies, such as Hansol PNS and Woojung Bio.The Incheon Center for Creative Economy & Innovation accelerates the innovative growth process of startups and contributes to building the local startup ecosystem, from direct investment in early-stage companies, securing research and development (R&D) funds through TIPS support, venture capital (VC) investment, follow-up investment linkage using ‘BiiG Wave IR’, to support for global expansion.Jaesun Lee, CEO of the Incheon Center for Creative Economy & Innovation, emphasized, “To revitalize the investment ecosystem, we are discovering promising startups and making direct investments”, and added, “Since 2023, we have been selected as a TIPS operator and are sparing no effort to support the companies we invest in so that they can grow rapidly with R&D funding from the Ministry of SMEs and Startups.” He added, “We are operating the ‘Big Wave IR&rsqu

2026.01.19 00:47:35
이재선 인천창조경제혁신센터 대표이사, “청년 해외진출기지 지원 사업, 글로벌 청년 CEO로 성장할 수 있는 기반을 마련”

2015년 개소한 인천창조경제혁신센터는 인천 관내 대표 창업 전문 지원기관이다. 2018년 인천 지역 최초 액셀러레이터에 등록한 센터는 보육, 사업화 지원, 직접 투자와 출자 사업 등을 통해 관내 창업·투자 생태계를 이끌어 왔다.인천창조경제혁신센터는 창업 전문 기관으로 ICCE 창업스쿨, 청년창업챌린지와 같은 다양한 창업 지원 사업을 통해 창업 기업의 혁신적인 성장을 지원하고 있다.이외에도 스타트업의 빠른 시장진입을 위해 다양한 오픈이노베이션 사업을 추진하고 있다. 인천창조경제혁신센터의 주요 파트너 대기업인 한진그룹과 KT그룹 이외에도 한솔PNS, 우정바이오 등 다양한 대중견기업과 오픈이노베이션 사업 확대를 통해 창업기업의 빠른 성장을 지원하고 있다.인천창조경제혁신센터는 초기 기업의 직접 투자부터, 팁스(TIPS) 지원을 통한 연구개발(R&D) 자금 확보, 벤처캐피털(VC) 출자 및 ‘빅웨이브(BiiG Wave) IR’을 활용한 후속 투자 연계, 글로벌 진출 지원까지 스타트업의 혁신 성장 프로세스를 가속화하며 지역 내 창업생태계 구축에 기여하고 있다.이재선 인천창조경제혁신센터 대표이사는 “투자생태계를 활성화하기 위해 유망한 스타트업을 발굴하여 직접 투자도 하고 있다”며 “2023년부터는 팁스(TIPS) 운영사로 선정돼 투자한 기업이 중소벤처기업부 R&D 자금을 지원받아 빠르게 성장할 수 있도록 지원을 아끼지 않고 있다”고 강조했다. 덧붙여 “빅웨이브 모펀드를 활용해 우수한 유망한 기업이 Series A 이상 투자유치를 받을 수 있도록 ‘빅웨이브 IR’사업을 운영하고 있다”고 말했다. 이 대표이사를 인천 연수구 인천창조경제혁신센터에서

2026.01.19 00:41:24
Yong-woo Kim, CEO of Busan Center for Creative Economy & Innovation, said, “As of our 10th anniversary in 2025, we have nurtured 2,374 startups, generated KRW 875.2 billion in revenue"

The Busan Center for Creative Economy & Innovation serves as a public accelerator and a core driver of the regional innovation ecosystem, playing a pivotal role across multiple areas including the discovery and nurturing of startups, the promotion of open innovation between large enterprises and startups, and direct investment and investment attraction support through fund formation. Yong-woo Kim, CEO of the Busan Center for Creative Economy & Innovation, said, “As we celebrate our 10th anniversary in 2025, we have driven the growth of numerous startups over the past decade and delivered tangible results,” adding, “As a result, we have supported 2,374 startups, generated KRW 875.2 billion in revenue, created 5,378 jobs, and attracted KRW 251 billion in investment, vitalizing the local startup ecosystem.” We met with CEO Kim at the Busan Center, located in Haeundae-gu, Busan.ProfileYong-woo Kim (Dennis Kim), CEO of the Busan Center for Creative Economy & Innovation CEO, Busan Center for Creative Economy & Innovation (Nov. 2023 – Present)Startup Policy Lead, Task Force for the Establishment of the Busan Startup Agency (Aug. 2022 – Oct. 2023)Research Professor, Drone Center, Dong-A University (May 2021 – Jul. 2022)Research Professor, ERC Research Institute, Pusan National University (Dec. 2013 – Oct. 2018)What are the key programs that the Busan Center for Creative Economy & Innovation is currently running?“We operate lifecycle-based support programs covering all stages of startup growth, from pre-startup and early-stage ventures to scale-ups, spanning initiatives such as fostering an entrepreneurial culture, accelerating promising companies, open innovation, global expansion, and investment. In particular, we are working to expand open innovation by building partnerships with a range of large and mid-sized enterprises, including our dedicated corporate partner, Lotte Group, and connecting t

2026.01.19 00:34:36
김용우 부산창조경제혁신센터 대표이사, “2025년 설립 10주년, 창업기업 육성 2,374개사, 매출액 8,752억원, 고용창출 5,378명, 투자유치 2,510억 원을 달성”

부산창조경제혁신센터는 공공액셀러레이터이자 지역 혁신 생태계의 핵심주체로서 스타트업 발굴·육성, 대기업·스타트업 간 오픈이노베이션 촉진, 펀드조성을 통한 직접투자 및 투자유치 지원 등 다방면에서 중추적인 역할을 수행하고 있다. 김용우 부산창조경제혁신센터 대표이사는 “2025년 설립 10주년을 맞이했으며, 지난 10년 간 수많은 스타트업의 성장을 견인하며 가시적인 성과를 창출했다”며 “그 결과 창업기업 육성 2,374개사, 매출액 8,752억원, 고용창출 5,378명, 투자유치 2,510억 원을 달성하며 지역 창업 생태계에 활력을 불어넣고 있다”고 말했다. 부산광역시 해운대구에 소재한 부산창조경제혁신센터에서 김 대표이사를 만났다.프로필김용우(Dennis Kim) 부산창조경제혁신센터 대표이사 (재)부산창조경제혁신센터 대표이사(2023.11. ~ 현재)부산창업청설립추진단 창업정책 담당(2022.08. ~ 2023.10.)동아대학교 드론센터 연구교수(2021.05. ~ 2022.07.)부산대학교 ERC연구소 연구교수(2013.12. ~ 2018.10.)부산창조경제혁신센터는 현재 어떤 사업들을 진행하고 있나요“창업문화 확산부터 기업발굴·진단 액셀러레이팅, 오픈이노베이션, 글로벌진출, 투자 등 예비·초기·스케일업 전 단계 생애주기별 지원 프로그램을 구축하여 운영하고 있습니다. 특히 전담 대기업 롯데를 비롯해 다양한 대·중견기업들과 파트너쉽을 구축해 스타트업 연결을 통한 오픈이노베이션 확산에 힘쓰고 있으며, 2025년 초 전국 19곳 창조경제혁신센터의 글로벌 거점센터로 선정되어 글로벌 인·아웃바운드 허브 역할도 수행 중입니다. 스타트업 투자 펀드는 총 120억 원 규모를 운용중이며,

2026.01.19 00:27:15
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] HYCONS develops targeted protein degraders and antibody-drug conjugates with a degradative platform.

HYCONS is a biotech company that designs and develops targeted protein degraders based on a hydrophobic tag (HT) platform, enabling an E3 ligase-independent protein degradation approach. CEO Kim Yoon-Jung (52) founded the company in September 2024.Flagship concept: targeted protein degrader with a hydrophobic tag. Unlike PROTACs, which recruit an E3 ligase, HYCONS’ degraders carry a hydrophobic tag to direct degradation of the target protein.Context on PROTACs: PROTACs link a ligand for an E3 ligase with a ligand for the target protein, bringing them into proximity so the E3 ligase tags the target with ubiquitin for proteasomal degradation. HYCONS’ HT-based degraders aim to overcome PROTAC limitations by not relying on a specific E3 ligase, offering broader applicability and potentially better cell permeability due to smaller molecular weight.HYCONS has developed the HyMAP platform for rapid design of HT-based degraders and envisions a platform capable of later adding antibodies to create DACs.Business model: rather than pursuing full clinical trials in-house, HYCONS focuses on licensing and co-development through a platform approach. They plan to engage in global partnerships at BIO USA, BIO Europe, JP Morgan Healthcare, and leverage Seoul Bio Hub’s international expansion programs to enter overseas markets.Funding: HYCONS has not yet taken external investments but is actively pursuing seed funding. Given the global interest in proteolysis-targeting technologies, discussions with local VCs and strategic investors are underway. The seed round aims to fund research infrastructure and PoC data enhancements, with a view to moving to pre-A in the following year.Future plans: “Short-term, rapidly secure data on our current molecules and target selection for the TIPs program next year; mid-term, achieve preclinical PoC data to validate the platform, and reinforce core researchers to strengthen platform capabilities; long-term, advance HT degraders

2026.01.19 00:16:56
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] CURAHEAL BIO develops health measurement solutions and functional cosmetics

CURAHEAL BIO creates lifestyle-oriented health measurement solutions and functional cosmetics based on bio-healthcare technology, guided by the philosophy “When healthy habits become science, life improves.” CEO Nam Hanmin (40) founded the company in November 2023.flagship items ZeroZeroCheck, a portable test kit that easily checks sugar content in beverages. It visualizes sugar presence, usable in cafes, schools, and homes for health management and education of children’s eating habits. It features a visualized sugar content approach and differentiates itself by verifying “added free sugar” independent of blood glucose. Developed on food hygiene and chemical analysis-based R&D, with proven accuracy and safety. Future expansion includes AI-based automatic analysis of sugar and salinity.Eye-Friendly Sunscreen, a non-irritating sunscreen market pioneer that eliminates eye sting. Uses a combination of hypoallergenic filters (DHHB, MBBT) with soothing ingredients like β-Glucan, Niacinamide, and oat extract to provide strong SPF50+/PA++++ without eye irritation. Completed three-function Korean MFDS certification (UV protection, whitening, wrinkle reduction); lacks white cast and tackiness, well-received by men and office workers.ZeroZeroCheck competitive edge: creates a new market category for beverage sugar measurement. It’s an intuitive kit usable by non-experts, with experiential programs for cafes, schools, and hospitals. Potential for expansion into global diet-management solutions integrated with AI analysis.Eye-Friendly Sunscreen competitive edge: non-irritating patent formula, vegan and FDA-listed ingredients enabling global exports, and attractive price (roughly 30–40% cheaper than international premium brands).CURAHEAL BIO is pursuing tailored marketing for both products. ZeroZeroCheck targets B2C (online store) and B2B (cafes, schools) channels, with listings on Naver Smart Store and Coupang, along with experi

2026.01.19 00:14:02
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] CoreMotion is a startup specializing in pelvic floor rehabilitation solutions.

CoreMotion develops and commercializes pelvic health physical therapy solutions to broaden access and enable self-management. CEO Heeju Han founded the company in March 2025.“Io pelvic health rehabilitation is an interdisciplinary field that includes not only abdominal and pelvic floor health but also urinary and bowel function and sexual health. Pelvic floor dysfunction affects 20–40% of the global population, but is often under-addressed in rehabilitation before medicine or surgery, due to social barriers. I wanted to help more people receive treatment.”The product lineup centers on three key items, with the flagship being PeriK (Pelvic Floor Rehabilitation Indicator Measurement and Analysis-based Reporting System). Unlike conventional methods that measure only vaginal or anal pressure, PeriK analyzes pelvic floor movement vectors (speed and direction) using tissue stiffness measurements and 3D motion data to derive motion quality and balance, estimating strength and endurance for a multifaceted assessment of pelvic floor function. The concept also includes personalized self-rehabilitation exercise reports, with clinical trial-ready product refinement underway.Another product is PhysioWand (insertable pelvic floor self-rehabilitation device), designed with curvature and ergonomics tailored to Asian body types; it drew strong attention when showcased at KIMES BUSAN this year.The third item is DRUDA, an ergonomic pelvic belt designed to support and maintain proper pelvic alignment around the sacroiliac joint, slated for release within the year.CoreMotion’s competitive edge lies in the expertise of a CAPP-pelvic specialist credential from the American Physical Therapy Association, extensive networking with domestic and international clinicians, and founder’s direct patient-care experience. This foundation has helped secure university hospital networks for clinical validation and IRB alignment, ensuring the technology translates from quan

2026.01.19 00:11:43
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] Jaram Park, CEO of Kindly Vital

Kindly Vital operates under the 20YY (20 Years Younger) brand, focusing on health foods that support slow aging through a blend of scientific basis and emotional engagement. Jaram Park, CEO, founded the company in January 2025.“Our mission under the slogan Live Kindly, Care Fully is to practice small acts of body and mind care, spreading kindness to ourselves and those around us to help build a better world. I started with a simple, actionable health food idea—an easy self-care step that anyone can adopt. In the long run, these small acts will accumulate, stabilize the company’s own sales, and evolve into a data-driven personal health management platform that supports slow aging.”The flagship item is AlphaCD Eggshell Membrane Plus. It emerged from the real world problem of weight gain increasing joint load. Many middle-aged women experience weight gain during menopause, with abdominally centered weight gain increasing knee and lower back stress. Over roughly a decade around menopause, average weight increases of 8–10kg occur, substantially elevating joint strain. Market products typically focus separately on weight management or joint health; Kindly Vital combines them to address both.Alpha-cyclodextrin (α-CD) is a natural dietary fiber that adsorbs about 9 g of fat per gram, aiding weight control. The nacreous membrane powder is rich in cartilage critical components such as chondroitin, hyaluronic acid, collagen, and fibronectin. Together, AlphaCD Nan-egg Membrane Plus offers a product that supports both dieting and joint health, forming a health routine that reduces bodily strain during exercise-driven health cycles.Kindly Vital’s competitive edge lies in targeting root causes. While many products treat symptoms, this company addresses weight-driven joint pressure and the resulting reduced ability to exercise, which perpetuates weight gain. By combining fat-adsorption with cartilage-supporting ingredients, the product aims

2026.01.19 00:10:00
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] A startup that manufactures and sells spine implants, aiming to improve existing solutions, GC

GC designs and manufactures spine implants, currently developing a degenerative intervertebral fusion device specialized for reoperation. CEO Kim Yun Seok (34) founded the company in November 2023.Flagship item, a spine implant that enables patients who have become unable to perform daily activities due to trauma or degenerative disease to return to normal life.A key feature of GC’s spine implants is that subsequent surgeries can be performed without access to the previous hospital’s patient data or product history.GC is expanding through direct sales to surgeons and spine specialists, and by establishing channels via the Neurosurgery and Orthopedic Associations.GC completed the Knowledge Venture Camp 16 by the Korea Technology Finance Corporation (Korea Techno-venture Fund) and has engaged with several investors with support from the DaeRae Strategy Commercialization Center. The company also plans AC/VC meetings through the Startup Package.How did the founder start the company? “Our product’s standout is a reoperation-focused intervertebral fusion device. The demand is growing, but users often don’t know the specifics of previously used products. I wanted to address on-site challenges and contribute to the advancement of medical devices through implant and instrument manufacturing.”Since founding, Kim says he feels daily purpose, and he is especially gratified when a patient’s condition improves using their product. He also takes pride when a company previously uninterested in their product continues to buy it after trial.Future plans, “First, develop all spine implant products in addition to the current intervertebral fusion device, with the ultimate goal of becoming Korea’s No. 1 medical device company. We aim to export domestically and internationally and develop all medical devices used in spinal implants and orthopedic devices.”Establishment date: November 2023Main business: Spine implants (medical de

2026.01.19 00:08:08
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] reemarc, developing a next generation orthodontic platform

reemarc is a digital healthcare startup developing a next-generation orthodontic platform with a mission to make world-class orthodontic care more accessible, efficient, and patient-centered. Founded in March 2023 by Dr. Jeong Rae Cho, reemarc seeks to modernize orthodontic treatment through digital technology and global connectivity.Dr. Cho spent more than a decade practicing as a board-certified orthodontist in New York, treating patients from diverse cultural and geographic backgrounds. Through his clinical experience, he directly encountered the inefficiencies and inconveniences of traditional orthodontic systems—insights that ultimately motivated him to pursue entrepreneurship and reimagine how orthodontic care could be delivered in a more connected and patient-focused way.“While practicing in New York, I was able to meet patients from all over the world. At the same time, I realized that orthodontic care remains unnecessarily complex and inconvenient. Treatment quality and access were often limited by geography. reemarc began with a simple question: How can we deliver high-quality orthodontic care to more people, regardless of where they are?”reemarc’s platform digitally connects patients with a global network of orthodontic clinics while providing an end-to-end solution that manages each stage of orthodontic treatment. By digitizing treatment workflows and patient monitoring, the platform improves accessibility and convenience for patients, while enabling clinics to operate more efficiently and deliver more consistent care. “At its core, reemarc is about the digital transformation of orthodontic treatment,” Dr. Cho explained. “We are building an infrastructure that allows doctors to focus more on the quality of care and patients to experience treatment that fits seamlessly into their daily lives.”Dr. Cho also shared his thoughts on the startup journey. “Startups inevitably face unexpected challenges and ob

2026.01.19 00:06:19
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] Jungwhoi Lee, CEO of DiaBlood

DiaBlood leverages AI to design and validate anticancer and rare disease therapeutics. The company aims to accelerate the development of promising cancer and rare-disease treatments. CEO Lee founded the company in October 2023.“I earned my PhD in brain engineering at KAIST and have conducted over a decade of research on brain tumors and pancreatic cancer. Recently, I studied prominent anticancer targets and published results in overseas top-tier journals, which led me to start this venture. In 2019, overseas research teams spent years studying hypoxia-inducible factor 1A (HIF-1α) and won a Nobel Prize, through my work I realized that HIF-1α can be expressed and sustained under specific conditions, making cancer more aggressive. I aim to develop drugs that neutralize this action.”DiaBlood’s competitive edge lies in using AI systems to rapidly design and validate anticancer and rare disease therapies.“Our goal is to develop effective anticancer drugs and license the technology to major pharmaceutical companies, exploring multiple pathways for commercialization. Since we are at the early stages, we plan to actively pursue funding starting next year.”How did the founder start the company? “While pursuing my PhD at KAIST, entrepreneurship naturally came to mind. The area I’m best at is drug development. We are using initial funding from the Startup Package effectively and efficiently.”Future plans, “Develop effective anticancer drugs to help more people beat cancer, and give back the benefits I received at KAIST to society.”Establishment date : October 2023Main business : Anticancer drug development / Anticancer MD cream developmentAchievements : First anticancer drug development completedreporter jinho leejinho2323@hankyung.com

2026.01.19 00:04:30
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] A company that manufactures and OEM supplies products based on medical field experience, DASON

DASON manufactures its products based on medical field experience and provides OEM supply. CEO Shin Dong Gun founded the company in May 2023.DASON’s products are actually used at Korea’s five major hospitals and by more than 15 other companies.“I started as a sales representative in the medical device industry and spent nearly 20 years advancing to the director of a corporate research lab. Throughout that time I felt a widening gap between what the medical field requires and the realities of manufacturing. That gap motivated me to shift toward entrepreneurship first in marketing as a salesperson and later as a research-lab director, and to launch a startup before it’s too late.”The representative item is the silicone drape used in tattoo removal. Traditional tattoo removal often requires multiple laser sessions, which is time consuming, painful, and costly for patients. DASON’s drape is designed to deliver laser energy more efficiently and minimize skin damage, greatly reducing the number of sessions. The core technology lies in maximizing laser penetration by leveraging the physical properties and structural design of the silicone.“The biggest downside of tattoo removal is the long procedure time and high pain. However, with this drape, patient pain is reduced, and clinicians can remove tattoos more conveniently. Typically, tattoo removal takes about 15 months, with sessions once a month. If a bubble forms during laser treatment, the laser cannot reach the dermis, and the procedure must be stopped.When you apply adhesive to the bubble area and cover it with the silicone drape, the bubble disappears, allowing 2–3 additional laser passes. When covered, the drape enables laser transmission to the dermis and epidermis, shortening the treatment period and making tattoo removal easier for physicians.”Since his days as a salesman, Shin has built steady relationships with hospitals, doctors, and medical staff. That netw

2026.01.19 00:02:51
[2025 The CEO of Jeju National University Early-Stage Startup Package Deep Tech Selection] NEST develops wearable devices that analyze autonomic nervous system activity and emotions in real time

NEST is an AI healthcare company whose main business is developing the wearable device ‘MIND EASE™’ that analyzes autonomic nervous system activity and emotions in real time. Selected for the NVIDIA Inception program, it is building a global AI-optimized environment, and it provides a non-pharmacological treatment support system through the world’s first Autonomic Activity Neural Vector (AANV) and Neural Emotion Analysis (NEA) engines. The ultimate goal is to decode the ‘emotional language’ of children with autism and ADHD to help families and therapists empathize more effectively. CEO Jang Sungwon (42) founded the company in February 2024.“I have more than 15 years of experience in precision machinery and medical devices since 2008. I’ve worked with global companies like Continental, Dentsply Sirona, and Alma CAM, leading various projects from smart factory equipment design to the development of class 2 medical devices. Since 2022, I’ve expanded into health tech and AI healthcare, completing a POC with BMW.”The flagship item is ‘MIND EASE™’ a wearable device that predicts and prevents emotional explosions (meltdowns) or panic in children with autism or ADHD five minutes in advance. The core idea is to make complex autonomic nervous system data, traditionally measured only in hospitals, easily accessible in real time.Hardware is a patch-style sensor worn on the chest, measuring HRV (heart rate variability) and ECG (electrocardiography) at 250 Hz, with Edge AI processing data directly on the device. The software combines a Valence/Arousal model with a second derivative along the time axis to compute the AANV autonomic nervous acceleration (d²AANV/dt²). This enables capturing rapid changes in emotion and autonomic nervous activity, so, for example, when a child’s stress is imminent, the device provides customized feedback through vibration, sound, or a VCM (vibration channel

2026.01.19 00:01:22

처음 이전 6 7 8 9 10 다음 맨끝